Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

The document concludes that individualized treatments for hair issues are effective, certain hair changes can indicate neurocutaneous diseases, specific lotions improve skin health, laser hair removal works but needs more study on long-term effects, men's cosmetics are diverse, peeling is effective but can have side effects, and facial pigmentation is often due to overactive skin cells.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Blood removal and birth control pills both helped with hormone levels in women with PCOS, but birth control was better for regular periods and blood removal had fewer side effects.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Most adult women with PCOS in Port Harcourt, Nigeria, have high levels of bad fats in their blood, especially younger women.

Centratherum anthelminticum seed extract effectively treats Polycystic Ovary Syndrome in rats.

New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.

Fish oil improves skin health in people with diabetes and high cholesterol.

Early hair loss in men and women may indicate a higher risk of heart disease and metabolic problems.

Calcineurin inhibitors, used in kidney transplants, can cause a wide range of side effects including kidney damage and other health issues.

Early balding in young Indian men may indicate a higher risk of metabolic syndrome and potential heart disease.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Wet cupping blood has different components than regular venous blood, which might affect skin disorder treatments.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Omega-6 and LDL cholesterol increase the risk of hair loss.

People with male pattern baldness are more likely to have metabolic syndrome.

Mutations in the LSS gene cause a rare type of hereditary hair loss.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

High-intensity interval training improves certain hormone levels and lipid profiles in women with PCOS.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Curcumin may improve blood sugar levels and cholesterol in people with PCOS, but more research is needed.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.